Details.
Includes regulatory due diligence and gap analysis, dossier and technical file evaluation, competitive intelligence, presubmission meetings, resubmission strategies, bioequivalence and clinical strategies, comparable overseas regulator pathways, ACCESS consortium pathways, Project Orbis pathways, priority review and abbreviated evaluation pathways, and provisional registration pathways.